Abstract
BackgroundRheumatoid arthritis (RA) consists of two syndromes, one autoantibody-positive and one autoantibody-negative. Existing data on the relation between age of onset and prevalence of autoantibodies were conflicting. Therefore this multicohort study assessed the age of onset in relation to the presence of autoantibodies. The association with characteristics of the anti-citrullinated protein antibodies (ACPA) response was also explored.MethodsThe 1987 criteria-positive RA patients included in the Leiden EAC, BARFOT, ESPOIR, Umeå and Lund cohorts (n = 3321) were studied at presentation for age of onset and the presence of ACPA, rheumatoid factor (RF) and anti-carbamylated protein (anti-CarP) antibodies. Logistic regression analyses were performed; effect sizes were summarized in inverse-weighted meta-analyses. Within ACPA-positive RA, ACPA level was studied in all cohorts; ACPA isotypes, ACPA fine specificity and ACPA avidity index and clinical characteristics were studied in the Leiden EAC.ResultsFrom the age of 50 onward, the proportion of ACPA-negative RA patients increased with age in the five cohorts. Similar observations were made for RF and anti-CarP. The composition of the ACPA response did not change with increasing age of onset with respect to titer, isotype distribution, fine specificity and avidity index. With increasing age of onset, RA patients smoked less often, had higher acute phase reactants and more often had a sub(acute) symptom onset.ConclusionsData of five cohorts revealed that with older age of onset ACPA-negative RA is more frequent than ACPA-positive RA, while characteristics of ACPA-positive RA as judged by the composition of the ACPA response appeared not age dependent. Further biologic studies are needed to characterize the pathogenesis of ACPA-negative polyarthritis at older age and to promote personalized treatment decisions in ACPA-negative patients in daily practice.
Highlights
Rheumatoid arthritis (RA) consists of two syndromes, one autoantibody-positive and one autoantibody-negative
Patients The association between age at RA onset and prevalence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) was studied in all five RA cohorts (Leiden Early Arthritis Clinic (EAC), Better Anti-Rheumatic Farmaco-Therapy (BARFOT), et Suivi de POlyarthrites Indifférenciées Récentes (ESPOIR), Umeå, Lund) and anti-CarP was studied in two cohorts (Leiden EAC, BARFOT)
ACPA prevalence decreased in RA patients with an older age at onset The proportion of ACPA-positive RA was plotted for all age categories in all five cohorts (Fig. 1)
Summary
Rheumatoid arthritis (RA) consists of two syndromes, one autoantibody-positive and one autoantibody-negative. Existing data on the relation between age of onset and prevalence of autoantibodies were conflicting This multicohort study assessed the age of onset in relation to the presence of autoantibodies. In addition to ACPA, there is some evidence suggesting that there are different characteristics of RA patients presenting at an older age. Some studies showed lower frequencies of autoantibodies in RA patients presenting at older age [9,10,11,12,13,14], while other studies observed no differences [15, 16] or showed a nonsignificant trend toward a higher prevalence of ACPA in RA patients presenting at older age [17, 18]. The association between age of onset and the distribution of ACPA-positive RA versus ACPA-negative RA remains to be established
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
